Brian Irving

September 16, 2020 | Corporate Counsel

All public companies must consider the anticipated scrutiny they will receive from the U.S. Securities and Exchange Commission and the possible risk they face from SEC Enforcement if they do not proceed with caution.

By Britt Latham and Brian Irving

6 minute read

July 10, 2020 | Corporate Counsel

The health care industry must be particularly vigilant about protecting against future enforcement risks because it is a highly regulated industry facing an enforcement perfect storm—fast cash, poor guidance and retrospective review.

By Lisa Rivera and Brian Irving

8 minute read

June 09, 2020 | Corporate Counsel

There are steps prudent companies can take now, while still in crisis, to move forward with needed funding while reducing their risk in later government investigations and enforcement actions.

By Lisa Rivera and Brian Irving

7 minute read